Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia
暂无分享,去创建一个
Jialin Zheng | Howard E Gendelman | Huangui Xiong | H. Xiong | H. Gendelman | Jialin C. Zheng | H. Gelbard | A. Ghorpade | M. Thylin | Y. Persidsky | Harris A Gelbard | Yuri Persidsky | Anuja Ghorpade | Robin L. Cotter | Michael R Thylin | Robin Cotter | Douglas Niemann | MyHanh Che | Yong-Chun Zeng | Robin B Shepard | Jennifer M Swartz | M. Che | Douglas Niemann | R. Cotter | Jennifer M. Swartz | R. Shepard | Yong-Chun Zeng | Myhanh Che
[1] A. Yakovlev,et al. Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury , 1997, The Journal of Neuroscience.
[2] K. Seamon,et al. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. , 1991, Journal of immunology.
[3] M E Greenberg,et al. Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.
[4] L. Epstein,et al. Simultaneous in situ detection of apoptosis and necrosis in monolayer cultures by TUNEL and trypan blue staining. , 1997, BioTechniques.
[5] H. Gendelman,et al. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. , 1991, Journal of immunology.
[6] Susan Zolla-Pazner,et al. Human Immunodeficiency Virus (HIV) Envelope Binds to CXCR4 Independently of CD4, and Binding Can Be Enhanced by Interaction with Soluble CD4 or by HIV Envelope Deglycosylation , 1998, Journal of Virology.
[7] S. Beebe,et al. Type I cAMP-dependent Protein Kinase Delays Apoptosis in Human Neutrophils at a Site Upstream of Caspase-3* , 1998, The Journal of Biological Chemistry.
[8] H. Gendelman,et al. No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytes. , 1992, AIDS research and human retroviruses.
[9] S. Swindells,et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin , 1994, Journal of virology.
[10] Masahiko Kuroda,et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.
[11] A. Casadevall,et al. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism , 1994, The Journal of experimental medicine.
[12] Justin C. McArthur,et al. Immunologic NO Synthase: Elevation in Severe AIDS Dementia and Induction by HIV-1 gp41 , 1996, Science.
[13] J J Goedert,et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) , 1998, Science.
[14] J. Schlessinger,et al. Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5 , 1997, The Journal of experimental medicine.
[15] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[16] A. Rizzino,et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. , 1995, Journal of immunology.
[17] George J. Augustine,et al. Local calcium signalling by inositol-1,4,5-trisphosphate in Purkinje cell dendrites , 1998, Nature.
[18] P. Chomczyński,et al. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.
[19] M. Hagiwara,et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.
[20] R. Doms,et al. CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.
[21] S. Lipton,et al. The Coat Protein gp120 of HIV‐1 Inhibits Astrocyte Uptake of Excitatory Amino Acids via Macrophage Arachidonic Acid , 1995, The European journal of neuroscience.
[22] J. Zheng,et al. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells. , 1997, Biochemical and Biophysical Research Communications - BBRC.
[23] R. Miller,et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Osathanondh,et al. Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.
[25] U. de Girolami,et al. Apoptosis induced by HIV-1 infection of the central nervous system. , 1996, The Journal of clinical investigation.
[26] J. Corbin,et al. Structure and function of cyclic nucleotide-dependent protein kinases. , 1994, Annual review of physiology.
[27] S. Nishikawa,et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.
[28] S. Snyder,et al. Lymphocyte Apoptosis: Mediation by Increased Type 3 Inositol 1,4,5-Trisphosphate Receptor , 1996, Science.
[29] J. Sodroski,et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.
[30] S. Snyder,et al. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Merrill,et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain , 1995, The Journal of experimental medicine.
[32] D. Giulian,et al. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Lipton. Neuronal injury associated with HIV-1: approaches to treatment. , 1998, Annual review of pharmacology and toxicology.
[34] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[35] U. de Girolami,et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. , 1998, The American journal of pathology.
[36] J. Merrill,et al. The mapping of HIV-1 gpl60 epitopes required for interleukin-1 and tumor necrosis factor a production in glial cells , 1995, Journal of Neuroimmunology.
[37] S. Døskeland,et al. Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. , 1997, Biochemical and biophysical research communications.
[38] B. Hyman,et al. Role of the β-Chemokine Receptors CCR3 and CCR5 in Human Immunodeficiency Virus Type 1 Infection of Monocytes and Microglia , 1998, Journal of Virology.
[39] S. Lipton,et al. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity , 1991, Neuron.
[40] J. Merrill,et al. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1 , 1992, Journal of virology.
[41] Michael Greenberg,et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4 , 1998, Current Biology.
[42] J. Meldolesi,et al. Effects of the HIV‐1 Envelope Glycoprotein gp120 in Cerebellar Cultures. [Ca2+]i Increases in a Glial Cell Subpopulation , 1993, The European journal of neuroscience.
[43] C. Mackay,et al. Chemokine receptors and T cell chemotaxis , 1996, The Journal of experimental medicine.
[44] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[45] Bernhard Moser,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[46] E. Ohlstein,et al. Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.
[47] D. Burke,et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.
[48] Wei Zhang,et al. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. , 1997, The American journal of pathology.
[49] J. Wojtowicz,et al. Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices , 1996, Brain Research.
[50] A. Marks,et al. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis , 1997, Molecular and cellular biology.
[51] L. Schweitzer,et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. , 1997, Journal of immunology.
[52] J. Madsen,et al. Immunoreactivity in pituitary gonadotropes and hypothalamic vasopressinergic neurons for the monoclonal antibody INO , 1988, Journal of Neuroimmunology.
[53] J. Glass,et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.
[54] B. Brew,et al. Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex , 1998, AIDS.
[55] L. Montagnier,et al. Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion , 1992, Annals of neurology.